BFM 89.9

HIGHLIGHTS  PRN2023
Podcast  >  Marketplace  >  The Marketplace  >  Johnson And Johnson- Rare Mutations Lung Cancer, and Targeted Therapies (PT2)

Johnson And Johnson- Rare Mutations Lung Cancer, and Targeted Therapies (PT2)

Dr Jennifer Leong, Consultant Clinical Oncologist, Sunway Medical Center

28-Nov-22 15:45

Johnson And Johnson- Rare Mutations Lung Cancer, and Targeted Therapies (PT2)

Genetic testing technology has improved our ability to identify mutations in lung cancer, which may lead to more aggressive and rapidly worsening disease. In tandem with genetic testing, new drugs are also being discovered every day to target these rare mutations. Consultant clinical oncologist Dr Jennifer Leong gives us a glimpse into how genetic testing and targeted therapy is the new future for lung cancer.


This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories:  managing diseasemedical advances

Tags:  sunway medical centerlung cancer





Play / Pause

Listen now : Enterprise Biz Bytes

Today’s Shows



6:00 AM

The 6AM Stretch

7:00 AM

World Market Watch

7:15 AM

Morning Brief

8:00 AM

The Breakfast Grille

Nizran Noordin, Director General, Islamic Tourism Centre

8:30 AM

Morning Brief

9:00 AM

Opening Bell

9:35 AM

People, Planet, Profit

10:05 AM

Open For Business

Yap Ming Hui, Whitman Independent Advisors

11:05 AM

Resource Centre

Ridhima Khanduja, Kincentric Malaysia

12:00 PM

Enterprise Biz Bytes

1:00 PM

The Breakfast Grille Repeat

2:05 PM

Live & Learn

The State of Discrimination in Malaysia

3:05 PM

Beyond the Ballot Box

The Plight of Stateless People in Sabah

4:05 PM

Health & Living

Because Feelings Matter #23: Caring From Inside Out

5:00 PM

The Evening Edition

5:35 PM

Today On Twitter

6:05 PM

Inside Story

7:05 PM

The Evening Edition

7:35 PM

Popcorn Culture

8:05 PM

By The Book

9:00 PM

Bar None

10:00 PM

Lagu-Lagu Dulu-Dulu